NFKB1 and autoimmune disease: While NF-κB inhibitors have been explored in autoimmune diseases and transplant rejection, prior studies have predominantly focused on their role in T cell-or macrophage-mediated inflammatory pathways (19, 24, 40, 41), with limited investigation into their function in DC-mediated Th17/Treg balance.